Impax, Dr. Reddy’s Settle Generic Parkinsons Drug Patent Dispute – Bloomberg Law
Impax, Dr. Reddy’s Settle Generic Parkinsons Drug Patent Dispute Bloomberg Law
PATENT NEWS
-
In: PATENT NEWS
-
In: PATENT NEWS
Axsome Therapeutics Resolves Generic Patent Litigation With Teva Over Depression Drug, Analyst Maintains Axsome As ‘Top Pick For 2025’ – Yahoo Finance
Axsome Therapeutics Resolves Generic Patent Litigation With Teva Over Depression Drug, Analyst Maintains Axsome As ‘Top Pick For 2025’ Yahoo Finance
-
In: PATENT NEWS
InnoMemory, NEC Nearing Settlement in Server Memory Patent Suit – Bloomberg Law
InnoMemory, NEC Nearing Settlement in Server Memory Patent Suit Bloomberg Law
-
In: PATENT NEWS
Shares in Biopharma Firm Axsome Surge Over 20% After Settling Teva Patent Dispute – TipRanks
Shares in Biopharma Firm Axsome Surge Over 20% After Settling Teva Patent Dispute TipRanks
-
In: PATENT NEWS
U.S. Patent Awarded to Autonomix for Cancerous Tumor Treatment – MPO-mag
U.S. Patent Awarded to Autonomix for Cancerous Tumor Treatment MPO-mag
-
In: PATENT NEWS
Gigaplex Remote Screening Technology Receives Patent – ExecutiveBiz
Gigaplex Remote Screening Technology Receives Patent ExecutiveBiz
-
In: PATENT NEWS
Apple is Hellbent on vastly improving the comfort level of future versions of Vision Pro headsets by introducing major improvements – Patently Apple
Apple is Hellbent on vastly improving the comfort level of future versions of Vision Pro headsets by introducing major improvements Patently Apple
-
In: PATENT NEWS
BlytzPay Announces New Patent Approval for Revolutionary Collections Platform – PR Newswire
BlytzPay Announces New Patent Approval for Revolutionary Collections Platform PR Newswire
-
In: PATENT NEWS
Changes at Regional Court Mannheim as judge Dirk Böttcher moves to UPC full time – JUVE Patent
Changes at Regional Court Mannheim as judge Dirk Böttcher moves to UPC full time JUVE Patent
-
In: PATENT NEWS
UPC Statistics: 60% Success Rate Patentees, Rapid, and Further Key Insights – JUVE Patent
UPC Statistics: 60% Success Rate Patentees, Rapid, and Further Key Insights JUVE Patent